02269

Wuxi Biologics (Cayman)

23.15

-0.10-0.43%

Closed16:08 05/13 HKT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE23.500/23.250

TODAY RANGE22.700-23.650

VOL43.77M

MARKET CAP94.03B

52 WEEK RANGE10.140-29.150

AVG VOL (3M)68.12M

% TURNOVER1.08%

TURNOVER1.02B

P/E (TTM)25.945

% RANGE4.09%

EPS(TTM)0.892

P/E(FORWARD)22.283

P/B2.082

BVPS11.118

DIVIDEND--

P/S5.055

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP94.03B

SHARES OUTSTANDING4.06B

NEXT EARNINGS08/19-08/25

FREE FLOAT4.06B

LOT SIZE500

EX-DIV DATE--

News

Press Releases

Financial Reports

Profile

Simply Wall St·4d ago
WuXi Biologics (Cayman) Inc.'s (HKG:2269) 27% Jump Shows Its Popularity With Investors
Simply Wall St·6d ago
WuXi Biologics (Cayman) (HKG:2269) Seems To Use Debt Quite Sensibly
Simply Wall St·04/04 01:04
Individual investors who have a significant stake must be disappointed along with institutions after WuXi Biologics (Cayman) Inc.'s (HKG:2269) market cap dropped by HK$12b
Reuters·03/25 10:30
WUXI BIOLOGICS FY ADJUSTED NET INCOME RMB 5,396.9 MILLION
Reuters·03/25 08:41
WUXI BIOLOGICS FY GROSS PROFIT RMB 7,650.8 MILLION
Simply Wall St·03/16 00:30
WuXi Biologics (Cayman) Inc. (HKG:2269) Stocks Shoot Up 28% But Its P/E Still Looks Reasonable
Reuters·03/11 03:18
WUXI BIOLOGICS INCLUDED IN S&P GLOBAL SUSTAINABILITY YEARBOOK 2025
Simply Wall St·03/04 23:58
WuXi Biologics (Cayman) Inc.'s (HKG:2269) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Simply Wall St·02/15 00:48
WuXi Biologics (Cayman) (HKG:2269) earnings and shareholder returns have been trending downwards for the last three years, but the stock ascends 9.4% this past week
Simply Wall St·01/25 00:28
WuXi Biologics (Cayman) Inc.'s (HKG:2269) P/E Is On The Mark
Dow Jones·01/20 08:00
China Pharma Group WuXi Gains as Trump's TikTok Move Buoys Mood
Dow Jones·01/07 06:19
WuXi Biologics to Sell Irish Vaccine Facility to Merck for $500 Million
Reuters·01/07 02:38
BUZZ-Hong Kong-listed WuXi Biologics falls as co sells Irish vaccine facility
Reuters·01/07 00:02
BRIEF-Candid Therapeutics Enters Into Agreement With Wuxi Biologics On Trispecific T-Cell Engager
Reuters·01/06 15:55
Deals of the day-Mergers and acquisitions

Same Industry

Name/Symbol

Change%

Price

Shanghai Haohai Biological Technology

06826

-1.48%

23.350

Wuxi Apptec

02359

-0.64%

62.400

Hangzhou Tigermed Consulting

03347

-1.47%

26.900

JOINN Laboratories (China)

06127

+0.10%

9.960

Pharmaron Beijing

03759

-1.45%

13.620

Frontage Holdings

01521

+4.59%

1.140

BBI Life Sciences

01035

0.00%

3.490

China Health Group

08225

+2.56%

0.160

Mingyuan Medicare Development

00233

0.00%

0.230

China Regenerative Medicine International

08572

0.010

Mabpharm

02181

0.00%

0.440

Viva Biotech Holdings

01873

+11.89%

1.600

China Regenerative Medicine International

08158

0.00%

0.360

TOT Biopharm International

01875

0.00%

1.800

Hua Medicine

02552

+1.04%

1.950

MicroPort NeuroScientific

02172

-1.28%

10.800

Alphamab Oncology

09966

+3.13%

6.600

SinoMab BioScience

03681

+1.64%

1.240

Lepu Biopharma

02157

-0.23%

4.270

Jacobio Pharmaceuticals Group

01167

+13.94%

4.250

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.